Literature DB >> 11599573

The inducible Hsp70 as a marker of tumor immunogenicity.

P R Clark1, A Ménoret.   

Abstract

Growing evidence indicates that the stress response in general and heat shock proteins (Hsps) in particular have a profound impact on tumor immunogenicity. In this study, we show that tumor cells subjected to a nonlethal heat shock stress are unable to form tumors in syngenic mice, whereas they do so in athymic nude mice. Moreover, heat-shocked MethA immunity is tumor specific. Enhancement of T-cell-mediated immunogenicity correlates with the expression of the inducible Hsp70 but not the constitutive Hsc70. These observations have a bearing on the proposed functional role of Hsp-peptide association in antigen processing and presentation by major histocompatibility complex I molecules under normal and stressful conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599573      PMCID: PMC434389          DOI: 10.1379/1466-1268(2001)006<0121:tihaam>2.0.co;2

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  23 in total

1.  Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography.

Authors:  P Peng; A Ménoret; P K Srivastava
Journal:  J Immunol Methods       Date:  1997-05-12       Impact factor: 2.303

2.  Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.

Authors:  A Melcher; S Todryk; N Hardwick; M Ford; M Jacobson; R G Vile
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Structural analysis of substrate binding by the molecular chaperone DnaK.

Authors:  X Zhu; X Zhao; W F Burkholder; A Gragerov; C M Ogata; M E Gottesman; W A Hendrickson
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

4.  Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in associated with an increased sensitivity to lysis mediated by adherent natural killer cells.

Authors:  C Botzler; R Issels; G Multhoff
Journal:  Cancer Immunol Immunother       Date:  1996-12       Impact factor: 6.968

5.  Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells.

Authors:  G Multhoff; C Botzler; L Jennen; J Schmidt; J Ellwart; R Issels
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

6.  Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation.

Authors:  A D Wells; S K Rai; M S Salvato; H Band; M Malkovsky
Journal:  Int Immunol       Date:  1998-05       Impact factor: 4.823

7.  Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.

Authors:  A Ménoret; Y Patry; C Burg; J Le Pendu
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

8.  Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.

Authors:  N E Blachere; Z Li; R Y Chandawarkar; R Suto; N S Jaikaria; S Basu; H Udono; P K Srivastava
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

9.  Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.

Authors:  A M Ciupitu; M Petersson; C L O'Donnell; K Williams; S Jindal; R Kiessling; R M Welsh
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Heat shock protein 70-associated peptides elicit specific cancer immunity.

Authors:  H Udono; P K Srivastava
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  14 in total

1.  Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Authors:  Irena Adkins; Lenka Sadilkova; Nada Hradilova; Jakub Tomala; Marek Kovar; Radek Spisek
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

2.  Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.

Authors:  Carolina Torronteguy; Antonio Frasson; Felipe Zerwes; Erik Winnikov; Vinicius Duval da Silva; Antoine Ménoret; Cristina Bonorino
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells.

Authors:  Desheng Weng; Stuart K Calderwood; Jianlin Gong
Journal:  Methods Mol Biol       Date:  2011

4.  Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer.

Authors:  Yusei Kanazawa; Hajime Isomoto; Mikio Oka; Yoshitsugu Yano; Hiroshi Soda; Saburo Shikuwa; Fuminao Takeshima; Katsuhisa Omagari; Yohei Mizuta; Kunihiko Murase; Toru Nakagoe; Kenzo Ohtsuka; Shigeru Kohno
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 5.  Facets of heat shock protein 70 show immunotherapeutic potential.

Authors:  Stephen M Todryk; Michael J Gough; A Graham Pockley
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

6.  Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine.

Authors:  David G Casey; Joanne Lysaght; Tharappel James; Andrew Bateman; Alan A Melcher; Stephen M Todryk
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

7.  Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.

Authors:  Chen-Hsiung Yeh; Richard Tseng; Zhong Zhang; Jorge Cortes; Susan O'Brien; Francis Giles; Alison Hannah; Zeev Estrov; Michael Keating; Hagop Kantarjian; Maher Albitar
Journal:  Leuk Res       Date:  2008-08-19       Impact factor: 3.156

8.  Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.

Authors:  Christian Moser; Christin Schmidbauer; Ulrich Gürtler; Catharina Gross; Mathias Gehrmann; Gerald Thonigs; Karin Pfister; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2002-10       Impact factor: 3.667

Review 9.  The Role of the NKG2D in Vitiligo.

Authors:  Lourdes Plaza-Rojas; José A Guevara-Patiño
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

10.  Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors.

Authors:  Rong Fan; Cheng Wang; Yang Wang; Ping Ren; Pingping Gan; Hui Ji; Zian Xia; Suiyu Hu; Qiongyao Zeng; Wei Huang; Yebin Jiang; Xi Huang
Journal:  J Transl Med       Date:  2012-05-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.